KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Change in Accured Expenses: 2014-2025

Historic Change in Accured Expenses for Zoetis (ZTS) over the last 11 years, with Sep 2025 value amounting to $101.0 million.

  • Zoetis' Change in Accured Expenses fell 18.55% to $101.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.0 million, marking a year-over-year decrease of 42.31%. This contributed to the annual value of $114.0 million for FY2024, which is 70.15% up from last year.
  • Latest data reveals that Zoetis reported Change in Accured Expenses of $101.0 million as of Q3 2025, which was up 180.56% from $36.0 million recorded in Q2 2025.
  • Over the past 5 years, Zoetis' Change in Accured Expenses peaked at $165.0 million during Q4 2021, and registered a low of -$222.0 million during Q1 2022.
  • Its 3-year average for Change in Accured Expenses is $16.2 million, with a median of $36.0 million in 2025.
  • In the last 5 years, Zoetis' Change in Accured Expenses slumped by 208.33% in 2022 and then soared by 825.00% in 2024.
  • Zoetis' Change in Accured Expenses (Quarterly) stood at $165.0 million in 2021, then tumbled by 71.52% to $47.0 million in 2022, then spiked by 100.00% to $94.0 million in 2023, then decreased by 17.02% to $78.0 million in 2024, then fell by 18.55% to $101.0 million in 2025.
  • Its Change in Accured Expenses stands at $101.0 million for Q3 2025, versus $36.0 million for Q2 2025 and -$140.0 million for Q1 2025.